Mónica Ortego

2.7k total citations
20 papers, 2.3k citations indexed

About

Mónica Ortego is a scholar working on Surgery, Cancer Research and Molecular Biology. According to data from OpenAlex, Mónica Ortego has authored 20 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 7 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Mónica Ortego's work include Lipoproteins and Cardiovascular Health (7 papers), Inflammatory mediators and NSAID effects (5 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Mónica Ortego is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Inflammatory mediators and NSAID effects (5 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Mónica Ortego collaborates with scholars based in Spain and United States. Mónica Ortego's co-authors include Jesús Egido, Miguel Ángel Hernández-Presa, Carmen Bustos, Gonzalo Hernández, José Tuñón, Luis Miguel Blanco‐Colio, Luís Ortega, C. Díaz, Juan José González Plaza and Marta Ruiz‐Ortega and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Mónica Ortego

19 papers receiving 2.2k citations

Peers

Countries citing papers authored by Mónica Ortego

Since Specialization

Citations

This map shows the geographic impact of Mónica Ortego's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mónica Ortego with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mónica Ortego more than expected).

Fields of papers citing papers by Mónica Ortego

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mónica Ortego. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mónica Ortego. The network helps show where Mónica Ortego may publish in the future.

Co-authorship network of co-authors of Mónica Ortego

This figure shows the co-authorship network connecting the top 25 collaborators of Mónica Ortego. A scholar is included among the top collaborators of Mónica Ortego based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mónica Ortego. Mónica Ortego is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neoadjuvant Chemoradiotherapy in Locally Advanced Gastric Adenocarcinoma: Long-Term Results and Statistical Algorithm to Predict Individual Risk of Relapse 2025 ·Cancers ·Mónica Ortego, (unknown), (unknown), (unknown), (unknown), (unknown), João Subtil, (unknown), Víctor Valentí, Agustín Tortajada, (unknown), (unknown), Javier Rodríguez	0
2	Hearts of some Antarctic fishes lack mitochondrial creatine kinase 2014 ·Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology ·Kristin M. O’Brien, Irina A. Mueller, (unknown), (unknown), Mónica Ortego	10
3	Effect of Intensive Atorvastatin Therapy on Prostaglandin E2 Levels and Metalloproteinase-9 Activity in the Plasma of Patients With Non-ST-Elevation Acute Coronary Syndrome††Conflicts of interest: Drs. Egido and Tuñón have participated on advisory boards and have been invited speakers for Pfizer. 2008 ·The American Journal of Cardiology ·Almudena Gómez‐Hernández, Eva Sánchez-Galán, Mónica Ortego, José Luis Martín‐Ventura, Luis Miguel Blanco‐Colio, Nieves Tarín, (unknown), Lorenzo López‐Bescós, Jesús Egido, José Tuñón	26
4	Atorvastatin Reduces the Expression of Prostaglandin E2 Receptors in Human Carotid Atherosclerotic Plaques and Monocytic Cells 2006 ·Journal of Cardiovascular Pharmacology ·Almudena Gómez‐Hernández, Eva Sánchez-Galán, José Luis Martín‐Ventura, Cristina Vidal, Luis Miguel Blanco‐Colio, Mónica Ortego, (unknown), Javier Serrano, Luís Ortega, Gonzalo Hernández, José Tuñón, Jesús Egido	46
5	HMG-CoA Reductase Inhibitors Reduce IκB Kinase Activity Induced by Oxidative Stress in Monocytes and Vascular Smooth Muscle Cells 2005 ·Journal of Cardiovascular Pharmacology ·Mónica Ortego, (unknown), Cristina Vidal, Eva Sánchez-Galán, Luis Miguel Blanco‐Colio, José Luis Martín‐Ventura, José Tuñón, Cristina Dı́az-Jullien, Gonzalo Hernández, Jesús Egido	26
6	Overexpression of COX-2, Prostaglandin E Synthase-1 and Prostaglandin E Receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: Regulation by nuclear factor-κB 2005 ·Atherosclerosis ·Almudena Gómez‐Hernández, José Luis Martín‐Ventura, Eva Sánchez-Galán, Cristina Vidal, Mónica Ortego, Luis Miguel Blanco‐Colio, Luís Ortega, José Tuñón, Jesús Egido	75
7	Possible Role of Parathyroid Hormone–Related Protein as a Proinflammatory Cytokine in Atherosclerosis 2003 ·Stroke ·José Luis Martín‐Ventura, Mónica Ortego, Pedro Esbrit, Miguel Ángel Hernández-Presa, Luís Ortega, Jesús Egido	63
8	Total fatty acid quantification as an estimator of total body fat content in broilers fed unsaturated diets. 2003 ·Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) ·(unknown), L. Cortinas, Mónica Ortego, A.C. Barroeta, (unknown)	4
9	3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation 2002 ·Atherosclerosis ·Luis Miguel Blanco‐Colio, Ana Villa, Mónica Ortego, Miguel Ángel Hernández-Presa, Angel Pascual, Juan José González Plaza, Jesús Egido	173
10	3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cells 2002 ·European Journal of Pharmacology ·Mónica Ortego, (unknown), Carmen Bustos, Luis Miguel Blanco‐Colio, Miguel Ángel Hernández-Presa, José Tuñón, Jesús Egido	11
11	Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells 2002 ·Atherosclerosis ·Miguel Ángel Hernández-Presa, José Luis Martín‐Ventura, Mónica Ortego, Almudena Gómez‐Hernández, José Tuñón, Purificación Hernández-Vargas, Luis Miguel Blanco‐Colio, Sebastián Mas, César Aparicio, Luís Ortega, Fernando Vivanco, (unknown), Cristina Dı́az-Jullien, Gonzalo Hernández, Jesús Egido	110
12	Red Wine Intake Prevents Nuclear Factor-κB Activation in Peripheral Blood Mononuclear Cells of Healthy Volunteers During Postprandial Lipemia 2000 ·Circulation ·Luis Miguel Blanco‐Colio, (unknown), Luis A. Álvarez-Sala, Carmen Bustos, Mónica Ortego, Miguel Ángel Hernández-Presa, (unknown), J.A. Gómez-Gerique, Jesús Millán, Jesús Egido	116
13	Atorvastatin reduces NF-κB activity and the expression of Interleukin-8, Metalloproteinase-3 and Cyclooxygenase-2 in a rabbit model of atherosclerosis 2000 ·Atherosclerosis ·Miguel Ángel Hernández-Presa, José Tuñón, Mónica Ortego, Sebastián Mas, José Luis Martín‐Ventura, Luis Miguel Blanco‐Colio, Almudena Gómez‐Hernández, Carmen Bustos, César Aparicio, Luís Ortega, J.A. Gómez-Gerique, (unknown), (unknown), (unknown), J. Egido	2
14	Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells 1999 ·Atherosclerosis ·Mónica Ortego, Carmen Bustos, Miguel Ángel Hernández-Presa, José Tuñón, C. Díaz, Gonzalo Hernández, Jesús Egido	309
15	HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis 1998 ·Journal of the American College of Cardiology ·Carmen Bustos, Miguel Ángel Hernández-Presa, Mónica Ortego, José Tuñón, Luís Ortega, Fernando Sabatel-Pérez, C. Díaz, Gonzalo Hernández, Jesús Egido	354
16	ACE Inhibitor Quinapril Reduces the Arterial Expression of NF-κB-Dependent Proinflammatory Factors but not of Collagen I in a Rabbit Model of Atherosclerosis 1998 ·American Journal Of Pathology ·Miguel Ángel Hernández-Presa, Carmen Bustos, Mónica Ortego, José Tuñón, Luís Ortega, Jesús Egido	99
17	3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture 1998 ·Circulation Research ·Carlos Guijarro, Luis Miguel Blanco‐Colio, Mónica Ortego, Covadonga Alonso, Alberto Ortíz, Juan José González Plaza, Cristina Dı́az-Jullien, Gonzalo Hernández, Jesús Egido	332
18	Angiotensin-Converting Enzyme Inhibition Prevents Arterial Nuclear Factor-κB Activation, Monocyte Chemoattractant Protein-1 Expression, and Macrophage Infiltration in a Rabbit Model of Early Accelerated Atherosclerosis 1997 ·Circulation ·Miguel Ángel Hernández-Presa, Carmen Bustos, Mónica Ortego, (unknown), G Renedo, Marta Ruiz‐Ortega, Jesús Egido	425
19	24 HMG-CoA reductase inhibition by atorvastatin (ATV) induces apoptosis of vascular smooth muscle cells (VSMC) in culture—role of isoprenoids of the mevalonate pathway 1997 ·Atherosclerosis ·Carlos Guijarro, Mónica Ortego, Alberto Ortíz, Miguel Ángel Hernández-Presa, Carmen Bustos, C. Díaz, Gonzalo Hernández, Jesús Egido	1
20	Effects and Interactions of Endothelin-1 and Angiotensin II on Matrix Protein Expression and Synthesis and Mesangial Cell Growth 1996 ·Hypertension ·Dulcenombre Gómez‐Garré, Marta Ruiz‐Ortega, Mónica Ortego, Raquel Largo, M.J. López-Armada, Juan José González Plaza, Eva González, Jesús Egido	140

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact